|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||10.55 - 10.94|
|52 Week Range||5.20 - 10.94|
|PE Ratio (TTM)||-56.25|
|Earnings Date||Nov 14, 2017 - Nov 20, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||8.67|
On a per-share basis, the Migdal Haemeq, Israel-based company said it had a loss of 10 cents. Losses, adjusted for stock option expense, came to 6 cents per share. The maker of lipid-based nutritional ...
Record INFAT ® Net Revenues of $13.3 Million. Generated Strong Cash Flow from Operations of $2.9 Million. Inventory Write-Off of $3.3 Million.
NEW YORK, NY / ACCESSWIRE / August 16, 2017 / Enzymotec Ltd. (NASDAQ: ENZY ) will be discussing their earnings results in their Q2 Earnings Call to be held August 16, 2017 at 8:30 AM Eastern Time. To listen ...